Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2022

01-02-2022 | Pulmonary Hypertension

Sickle cell disease related chronic thromboembolic pulmonary hypertension: challenging clinical scenario

Authors: Panagiotis Karyofyllis, Dimitrios Tsiapras, Eftychia Demerouti, Iakovos Armenis, Varvara Papadopoulou, Vassilis Voudris

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2022

Login to get access

Abstract

Sickle cell disease (SCD), a haemoglobinopathy characterized by chronic haemolysis with acute exacerbations and vascular occlusion episodes, may be complicated by pulmonary hypertension. The latter may be caused by chronic thromboembolic disease of pulmonary artery branches and its management is not well-defined. Herein, we present a case of SCD complicated by chronic thromboembolic pulmonary hypertension of subsegmental pulmonary artery branches successfully treated with endothelin receptor antagonists, orally administered prostacyclin analogs and balloon pulmonary angioplasty. This challenging case highlights the need for clinical awareness of chronic thromboembolic pulmonary hypertension as a specific and potentially curable form of pulmonary hypertension complicating SCD course that may necessitate combined pharmacologic and interventional management.
Literature
1.
go back to reference Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1801913CrossRef Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1801913CrossRef
2.
go back to reference Mehari A, Gladwin MT, Tian X, Machado RF, Kato GJ (2012) Mortality in adults with sickle cell disease and pulmonary hypertension. JAMA 307:1254–1256CrossRef Mehari A, Gladwin MT, Tian X, Machado RF, Kato GJ (2012) Mortality in adults with sickle cell disease and pulmonary hypertension. JAMA 307:1254–1256CrossRef
3.
go back to reference Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G et al (2011) A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 365:44–53CrossRef Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G et al (2011) A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 365:44–53CrossRef
4.
go back to reference Mehari A, Klings ES (2016) Chronic pulmonary complications of sickle cell disease. Chest 149:1313–1324CrossRef Mehari A, Klings ES (2016) Chronic pulmonary complications of sickle cell disease. Chest 149:1313–1324CrossRef
5.
go back to reference Gordeuk VR, Castro OL, Machado RF (2016) Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood 127:820–828CrossRef Gordeuk VR, Castro OL, Machado RF (2016) Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood 127:820–828CrossRef
6.
go back to reference Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR et al (2014) An official american thoracic society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med 189:727–740CrossRef Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR et al (2014) An official american thoracic society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med 189:727–740CrossRef
7.
go back to reference Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schönauer V et al (2005) Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 93:512–516CrossRef Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schönauer V et al (2005) Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 93:512–516CrossRef
8.
go back to reference Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G et al (2013) Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med 187:840–847CrossRef Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G et al (2013) Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med 187:840–847CrossRef
9.
go back to reference Barst RJ, Mubarak KK, Machado RF, Ataga KI, Benza RL, Castro O, ASSET study group* et al (2010) Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies. Br J Haematol 149:426–35CrossRef Barst RJ, Mubarak KK, Machado RF, Ataga KI, Benza RL, Castro O, ASSET study group* et al (2010) Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies. Br J Haematol 149:426–35CrossRef
10.
go back to reference Machado RF, Barst RJ, Yovetich NA, Hassell KL, Kato GJ, Gordeuk VR, walk-PHaSST Investigators and Patients et al (2011) Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood 118:855–64CrossRef Machado RF, Barst RJ, Yovetich NA, Hassell KL, Kato GJ, Gordeuk VR, walk-PHaSST Investigators and Patients et al (2011) Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood 118:855–64CrossRef
11.
go back to reference Weir NA, Saiyed R, Alam S, Conrey A, Desai HD, George MP et al (2017) Prostacyclin-analog therapy in sickle cell pulmonary hypertension. Haematologica 102:e163–e165CrossRef Weir NA, Saiyed R, Alam S, Conrey A, Desai HD, George MP et al (2017) Prostacyclin-analog therapy in sickle cell pulmonary hypertension. Haematologica 102:e163–e165CrossRef
12.
go back to reference DesJardin JT, Zier LS (2019) Successful use of pulmonary vasodilators in acute chest syndrome complicated by persistent right ventricular failure. Case Rep Cardiol 2019:4681392PubMedPubMedCentral DesJardin JT, Zier LS (2019) Successful use of pulmonary vasodilators in acute chest syndrome complicated by persistent right ventricular failure. Case Rep Cardiol 2019:4681392PubMedPubMedCentral
13.
go back to reference Mahesh B, Besser M, Ravaglioli A, Pepke-Zaba J, Martinez G, Klein A et al (2016) Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience. Eur J Cardiothorac Surg 50:537–541CrossRef Mahesh B, Besser M, Ravaglioli A, Pepke-Zaba J, Martinez G, Klein A et al (2016) Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience. Eur J Cardiothorac Surg 50:537–541CrossRef
14.
go back to reference Savale L, Habibi A, Lionnet F, Maitre B, Cottin V, Jais X et al (2019) Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease. Eur Respir J 54:1900585CrossRef Savale L, Habibi A, Lionnet F, Maitre B, Cottin V, Jais X et al (2019) Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease. Eur Respir J 54:1900585CrossRef
15.
go back to reference Karyofyllis P, Tsiapras D, Papadopoulou V, Diamantidis MD, Fotiou P, Demerouti E et al (2018) Balloon pulmonary angioplasty is a promising option in thalassemic patients with inoperable chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis 46:516–520CrossRef Karyofyllis P, Tsiapras D, Papadopoulou V, Diamantidis MD, Fotiou P, Demerouti E et al (2018) Balloon pulmonary angioplasty is a promising option in thalassemic patients with inoperable chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis 46:516–520CrossRef
Metadata
Title
Sickle cell disease related chronic thromboembolic pulmonary hypertension: challenging clinical scenario
Authors
Panagiotis Karyofyllis
Dimitrios Tsiapras
Eftychia Demerouti
Iakovos Armenis
Varvara Papadopoulou
Vassilis Voudris
Publication date
01-02-2022
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2022
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-021-02483-7

Other articles of this Issue 2/2022

Journal of Thrombosis and Thrombolysis 2/2022 Go to the issue